Episode 412: Metformin and the MeMeMe Study: Is It Time?
Dr. Kahn is hosting an online Reversing Heart Disease Summit. You can register now at: drtalks.com/summit/reversing-heart-disease
This week, he takes a deep dive into the potential role of metformin as a drug for cancer prevention, diabetes management, and anti-aging, reporting on several new studies, including the MeMeMe randomized trial. The data is compelling.
He also discusses several key topics, including a new study on statins reducing dementia risk, Omega-3’s role in slowing aging, the hidden harms of juicing, microplastics in the brain, menopause and artery health, luteolin for dark hair, and the impact of telemedicine coaching on diabetic heart patients.
More From Current Show
This week, Dr. Kahn presents the case of a patient seen this month at the Kahn Center for...
Listen Now This week, Dr. Kahn presents a new scientific statement by the American College of Cardiology on nutrition to...
Listen Now This week, as a bonus, Dr. Kahn interviews a Detroit clothing legend, Phil, who celebrated his 100th birthday...
Listen Now This week, Dr. Kahn brings back the topic of Mankai Duckweed, the smallest edible plant, which provides a...
Listen Now In this episode, Dr. Kahn interviews Ben Tammetta, founder of H2Biohacker, about inhaled molecular hydrogen. They discuss the...
Listen Now This week, Dr. Kahn discusses a large study on the impact of whole-grain consumption on heart health. The...
Listen Now This week, Dr. Kahn discusses two large new studies examining the role of routine coronary artery calcium CT...
Listen Now This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a...
Listen Now Related Episodes
No related episodes found.
